Iovance Biotherapeutics, Inc. (IOVA)
3.86
+0.07
(+1.85%)
USD |
NASDAQ |
Feb 27, 16:00
3.83
-0.03
(-0.78%)
After-Hours: 20:00
Iovance Biotherapeutics Total Assets (Quarterly) : 913.17M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Orthofix Medical, Inc. | 850.65M |
| InfuSystem Holdings, Inc. | 100.56M |
| Axogen, Inc. | 221.69M |
| KalVista Pharmaceuticals, Inc. | 339.93M |
| Lantheus Holdings, Inc. | 2.227B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 214.59M |
| Shareholders Equity (Quarterly) | 698.58M |
| Debt to Equity Ratio | 0.0708 |
| Current Ratio | 3.200 |
| Net Debt Paydown Yield | 0.54% |